49 results on '"Cuervas‐Mons, V"'
Search Results
2. Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir
3. Long-Term Survivors After Pediatric Liver Transplatation Are at Increased Risk for Development of Cardiovascular Disease Events: Analysis of 30 Cases
4. CC Genotype at rs12979860 of IL28B Is Associated With Lower Risk of New-onset Diabetes After Transplantation in Adult Patients With Liver Transplantation for Hepatitis C Cirrhosis
5. TT Genotype of Transforming Growth Factor Beta1 +869C/T Is Associated With the Development of Chronic Kidney Disease After Liver Transplantation
6. Toll-like Receptor 3 L412F Polymorphism May Protect Against Acute Graft Rejection in Adult Patients Undergoing Liver Transplantation for Hepatitis C-Related Cirrhosis
7. Breakthrough Rhinocerebral Mucormycosis in a Liver Transplant Patient Receiving Caspofungin
8. Right Adrenal Metastases of Hepatocarcinoma After Liver Transplantation: Case Report and Literature Review
9. Donor Infection and Transmission to the Recipient of a Solid Allograft
10. Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
11. Five-Year Follow-up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplantation
12. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation
13. Usefulness of mycophenolate mofetil in patients with chronic renal insufficiency after liver transplantation
14. De novo malignancies in liver transplantation
15. Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
16. Influence of Infection by Aspergillus in Arterial Complications After Liver Transplantation: Evolution and Results in 670 Transplants
17. Hepatitis C Virus Sensitivity to Combined Antiviral Therapy in Liver Transplant Versus Immunocompetent Patients
18. Incidence and outcome of De Novo malignancies after liver transplantation
19. Late orthotopic liver retransplant: indications and survival
20. Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases
21. Results of Liver Transplantation in Patients With Previous Portosystemic Shunts
22. Therapy of Intractable Pruritus With MARS
23. De novo malignancies and liver transplantation
24. Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality
25. Cardiovascular morbidity and obesity in adult liver transplant recipients
26. Effectiveness of low-dose intramuscular Anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report
27. Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas
28. Recurrence of primary biliary cirrhosis after liver transplantation
29. FRI-230 - The presence of two or more baseline NS5A resistance associated substitutions jeopardizes DAA treatment success in HCV patients
30. FRI-208 - Rapid liver fibrosis regression after sustained virological response in HCV patients treated with direct acting antivirals
31. SAT-286 - Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4
32. SAT-209 - Ledipasvir/Sofosbuvir for Recurrent Hepatitis C in Liver Transplant Recipients: A Real-Life Spanish Multicentre Experience
33. SAT-201 - Rapid Changes in Cholesterol in Chronic Hepatitis C Patients Treated with Antivirals and Potential Impacton Cardiovascular Risk
34. SAT-088 - Results of Radiofrequency Ablation in a Cohort of Cirrhotic Patients at Liver Transplantation
35. FRI-453 - Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Genotype 1, after Liver Transplantation: Efficacy and Safety
36. FRI-474 - Efficacy and Clinical Impact of Daclatasvir-Based Antiviral Therapy in Severe Recurrent Hepatitis C after Liver Transplantation. Results from a Multicenter Spanish Group
37. P0040 : Long-term cardiovascular mortality after liver transplantation: Analysis of risk factors
38. P908 EVEROLIMUS TREATMENT IN LIVER TRANSPLANTATION ACCORDING TO CLINICAL PRACTICE: A SPANISH MULTICENTRE COHORT
39. Documento de consenso de indicaciones de trasplante hepático
40. Effectiveness and security of mycophenolate mofetil as monotherapy in liver transplantation
41. Influence of immunosuppressive therapy in the incidence of chronic renal failure after liver transplantation
42. Infección por herpesvirus humano-6 y trasplante de órganos
43. Hepatocellular carcinoma: adjuvant chemotherapy postliver transplant
44. Induction of peripheral chimerism in an allogenic model of small bowel transplantation with intrathymic inoculation of donor-derived cells
45. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis
46. Capítulo 45 - Trasplante clínico de hepatocitos
47. Capítulo 15 - Inmunosupresión en el trasplante hepático
48. Role of the hepatic kupffer cells in the phagocytic splenic activity
49. Utility of hepatocellular transplantation into spleen as a temporary liver support in cirrhotic dogs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.